Liu Y - Search Results

1

Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy.

Zheng X, Yu X, Wang C, Liu Y, Jia M, Lei F, Tian J, Li C. Zheng X, et al. Among authors: liu y. Drug Deliv. 2022 Dec;29(1):1025-1037. doi: 10.1080/10717544.2022.2057616. Drug Deliv. 2022. PMID: 35363114 Free PMC article.

2

ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, targeted delivery of dexamethasone to arthritic joints.

Wang Y, Zhang D, Jia M, Zheng X, Liu Y, Wang C, Lei F, Niu H, Li C. Wang Y, et al. Among authors: liu y. J Drug Target. 2022 Nov;30(9):1006-1016. doi: 10.1080/1061186X.2022.2077949. Epub 2022 May 24. J Drug Target. 2022. PMID: 35549591

3

Microvesicle-camouflaged biomimetic nanoparticles encapsulating a metal-organic framework for targeted rheumatoid arthritis therapy.

Wang Y, Jia M, Zheng X, Wang C, Zhou Y, Pan H, Liu Y, Lu J, Mei Z, Li C. Wang Y, et al. Among authors: liu y. J Nanobiotechnology. 2022 Jun 3;20(1):253. doi: 10.1186/s12951-022-01447-0. J Nanobiotechnology. 2022. PMID: 35658866 Free PMC article.

4

Quercetin-3-O-α-L-arabinopyranosyl-(1→2)-β-D-glucopyranoside Isolated from Eucommia ulmoides Leaf Relieves Insulin Resistance in HepG2 Cells via the IRS-1/PI3K/Akt/GSK-3β Pathway.

Tang P, Tang Y, Liu Y, He B, Shen X, Zhang ZJ, Qin DL, Tian J. Tang P, et al. Among authors: liu y. Biol Pharm Bull. 2023 Feb 1;46(2):219-229. doi: 10.1248/bpb.b22-00597. Epub 2022 Dec 14. Biol Pharm Bull. 2023. PMID: 36517007 Free article.

5

Messenger Nanozyme for Reprogramming the Microenvironment of Rheumatoid Arthritis.

Jia M, Ren W, Liu Y, Wang C, Zheng X, Zhang D, Tan X, Li C. Jia M, et al. Among authors: liu y. ACS Appl Mater Interfaces. 2023 Jan 11;15(1):338-353. doi: 10.1021/acsami.2c16458. Epub 2022 Dec 29. ACS Appl Mater Interfaces. 2023. PMID: 36580409

6

Recent progress in therapeutic strategies and biomimetic nanomedicines based on neutrophils for inflammation treatment.

Liu Y, Yu Y, Wang M, Zhang C, Li C. Liu Y, et al. Nanomedicine (Lond). 2023 Feb;18(5):485-500. doi: 10.2217/nnm-2022-0211. Epub 2023 May 11. Nanomedicine (Lond). 2023. PMID: 37165973 Review.

7

Nano-modulators with the function of disrupting mitochondrial Ca²⁺ homeostasis and photothermal conversion for synergistic breast cancer therapy.

Wang C, Li T, Wang Z, Li Y, Liu Y, Xu M, Zhang Z, Deng Y, Cai L, Zhang C, Li C. Wang C, et al. Among authors: liu y. J Nanobiotechnology. 2023 Dec 4;21(1):465. doi: 10.1186/s12951-023-02220-7. J Nanobiotechnology. 2023. PMID: 38049882 Free PMC article.

8

Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy.

Liu Y, Zhang D, Zhang Z, Liang X, Yang X, Ding N, Nie Y, Li C. Liu Y, et al. J Colloid Interface Sci. 2024 Mar;657:598-610. doi: 10.1016/j.jcis.2023.11.156. Epub 2023 Nov 29. J Colloid Interface Sci. 2024. PMID: 38071809

9

Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy.

Zhang Z, Liang X, Yang X, Liu Y, Zhou X, Li C. Zhang Z, et al. Among authors: liu y. ACS Appl Mater Interfaces. 2024 Feb 14;16(6):6689-6708. doi: 10.1021/acsami.3c15686. Epub 2024 Feb 1. ACS Appl Mater Interfaces. 2024. PMID: 38302434 Review.

10

pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment.

Zheng X, Yang H, Zhang Z, Liang X, Liu Y, Wang C, Yang X, Tang J, Mao J, Nie Y, Zhou X, Li C. Zheng X, et al. Among authors: liu y. Acta Biomater. 2024 Apr 15;179:256-271. doi: 10.1016/j.actbio.2024.03.006. Epub 2024 Mar 12. Acta Biomater. 2024. PMID: 38484831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,201 results

Search Page

Filters